Patent · US Active

Modified von Willebrand Factor

US10253088B2 · kind B2 · utility

1Cited by
4References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2015
Grant dateApr 9, 2019
Priority date
Expiry dateJul 2, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/31
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a modified polypeptide which binds Factor VIII. The modified polypeptide comprises a sequence as shown in SEQ ID NO:3 in which the sequence comprises at least a modification at position 1 or 3 such that the modified polypeptide binds to Factor VIII with an off rate at least 5 fold lower than a reference polypeptide comprising an unmodified SEQ ID NO:3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.